Loading the section
Prices delayed by 15 minutes
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 16, 2026 | 9.45 | 9.92 | 9.44 | 9.87 | 20m |
| September 15, 2026 | 9.21 | 9.38 | 8.98 | 9.36 | 11m |
| September 14, 2026 | 8.56 | 9.41 | 8.54 | 9.26 | 21m |
| September 11, 2026 | 8.25 | 8.70 |
Based on reports through December 31, 2025
Iovance Biotherapeutics, Inc. (IOVA) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 263.5m $, net income was -391.0m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:825 INDUSTRIAL ROAD 4TH FLOOR, SAN CARLOS, CA, 94070, US
| 350m |
| TWSTTwist Bioscience Corporation | 157.26 | +9.92 % | 214m |
| HALOHalozyme Therapeutics, Inc. | 109.72 | +1.18 % | 211m |
| TECHBio-Techne Corp | 72.47 | +0.19 % | 186m |
| NBIXNeurocrine Biosciences, Inc. | 151.41 | +127.80 % | 173m |
| 8.08 |
| 8.60 |
| 12m |
| September 10, 2026 | 8.32 | 8.42 | 8.04 | 8.14 | 11m |
| September 09, 2026 | 8.66 | 8.73 | 8.32 | 8.43 | 12m |
| September 08, 2026 | 8.69 | 8.91 | 8.48 | 8.70 | 10m |
| September 04, 2026 | 8.74 | 8.90 | 8.64 | 8.79 | 8m |
| September 03, 2026 | 8.65 | 8.79 | 8.55 | 8.70 | 15m |
| September 02, 2026 | 8.31 | 8.69 | 8.30 | 8.62 | 12m |
| September 01, 2026 | 8.02 | 8.29 | 7.97 | 8.28 | 7m |
| August 31, 2026 | 7.95 | 8.17 | 7.66 | 8.17 | 12m |
| August 28, 2026 | 8.20 | 8.35 | 7.97 | 8.01 | 8m |
| August 27, 2026 | 8.08 | 8.32 | 7.95 | 8.26 | 7m |
| August 26, 2026 | 8.34 | 8.55 | 8.02 | 8.08 | 10m |
| August 25, 2026 | 8.16 | 8.48 | 8.03 | 8.44 | 12m |
| August 24, 2026 | 8.08 | 8.36 | 7.79 | 8.06 | 16m |
| August 21, 2026 | 9.08 | 9.30 | 8.15 | 8.29 | 28m |
| August 20, 2026 | 8.07 | 9.36 | 7.96 | 8.99 | 44m |
| August 19, 2026 | 7.20 | 8.06 | 7.19 | 7.99 | 24m |